177 related articles for article (PubMed ID: 34529143)
1. Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?
Rivas-Santiago B; Jacobo-Delgado Y; Rodriguez-Carlos A
Arch Immunol Ther Exp (Warsz); 2021 Sep; 69(1):25. PubMed ID: 34529143
[TBL] [Abstract][Full Text] [Related]
2. The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.
Brown RE; Hunter RL
Ann Clin Lab Sci; 2020 Mar; 50(2):287-288. PubMed ID: 32366572
[No Abstract] [Full Text] [Related]
3. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
[TBL] [Abstract][Full Text] [Related]
4. Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.
Findlay F; Proudfoot L; Stevens C; Barlow PG
Pathog Glob Health; 2016; 110(4-5):137-47. PubMed ID: 27315342
[TBL] [Abstract][Full Text] [Related]
5. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.
Hilchie AL; Wuerth K; Hancock RE
Nat Chem Biol; 2013 Dec; 9(12):761-8. PubMed ID: 24231617
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional cationic host defence peptides and their clinical applications.
Yeung AT; Gellatly SL; Hancock RE
Cell Mol Life Sci; 2011 Jul; 68(13):2161-76. PubMed ID: 21573784
[TBL] [Abstract][Full Text] [Related]
7. Immune status could determine efficacy of COVID-19 therapies.
Cully M
Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
[No Abstract] [Full Text] [Related]
8. A molecular arms race between host innate antiviral response and emerging human coronaviruses.
Wong LY; Lui PY; Jin DY
Virol Sin; 2016 Feb; 31(1):12-23. PubMed ID: 26786772
[TBL] [Abstract][Full Text] [Related]
9. Mining the tree of life: Host defense peptides as antiviral therapeutics.
Shartouny JR; Jacob J
Semin Cell Dev Biol; 2019 Apr; 88():147-155. PubMed ID: 29524585
[TBL] [Abstract][Full Text] [Related]
10. Lack of small animal model hinders MERS coronavirus research.
Devitt E
Nat Med; 2013 Aug; 19(8):952. PubMed ID: 23921729
[No Abstract] [Full Text] [Related]
11. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.
Khalili JS; Zhu H; Mak NSA; Yan Y; Zhu Y
J Med Virol; 2020 Jul; 92(7):740-746. PubMed ID: 32227493
[TBL] [Abstract][Full Text] [Related]
12. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
Chang R; Ng TB; Sun WZ
Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
[TBL] [Abstract][Full Text] [Related]
14. Coronaviruses - drug discovery and therapeutic options.
Zumla A; Chan JF; Azhar EI; Hui DS; Yuen KY
Nat Rev Drug Discov; 2016 May; 15(5):327-47. PubMed ID: 26868298
[TBL] [Abstract][Full Text] [Related]
15. MERS coronavirus has low pandemic potential, so far.
BMJ; 2013 Jul; 347():f4371. PubMed ID: 23843549
[No Abstract] [Full Text] [Related]
16. Future treatment strategies for novel Middle East respiratory syndrome coronavirus infection.
Adedeji AO; Sarafianos SG
Future Med Chem; 2013 Dec; 5(18):2119-22. PubMed ID: 24261888
[No Abstract] [Full Text] [Related]
17. [Cationic antimicrobial peptides: from innate immunity study to drug development. Up date].
Andrès E; Dimarcq JL
Med Mal Infect; 2007 Apr; 37(4):194-9. PubMed ID: 17306486
[TBL] [Abstract][Full Text] [Related]
18. Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action.
Drayton M; Deisinger JP; Ludwig KC; Raheem N; Müller A; Schneider T; Straus SK
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681833
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Peptides and Innate Lung Defenses: Role in Infectious and Noninfectious Lung Diseases and Therapeutic Applications.
Hiemstra PS; Amatngalim GD; van der Does AM; Taube C
Chest; 2016 Feb; 149(2):545-551. PubMed ID: 26502035
[TBL] [Abstract][Full Text] [Related]
20. Halting coronavirus polymerase.
Kirchdoerfer RN
J Biol Chem; 2020 Apr; 295(15):4780-4781. PubMed ID: 32277065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]